Since the launch of ChatGpt in 2022, artificial intelligence has transformed industries around the world, but the next evolution, Agent AI, promises to go deeper. According to Nvidia, Agent AI works dramatically, just like the Internet, leading AI systems that can not only generate content but also act autonomously. Unlike the generation AI that responds to prompts, Agent AI actively analyzes data and initiates actions throughout the complex workflow. Built on a digital ecosystem of large-scale language models, machine learning, and natural language processing, Agent AI enables true automation of multi-step processes with minimal human intervention. It remains a narrow AI form focused on special tasks rather than broad human reasoning, but the ability to dynamic decision-making and workflow optimization represents a major leap.
In clinical research, Agent AI is set up to drive advances in site and safety monitoring, protocol setup, patient recruitment, data management, and regulatory submission preparation. Predict risk, optimize recruitment strategies, automate protocol verification, and enhance data integrity in real time. Agent AI has marked a turning point, shifting AI from passive tools to active collaborators, poised to accelerate the future after clinical trials.
